The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Commercialization Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Summary Information section of this notice to Microbiotix, Inc. (``Microbiotix'') located in Worcester, Massachusetts.
Document
Prospective Grant of Exclusive Patent License: Inhibition of Plasmodial Surface Anion Channels for the Treatment or Prevention of Malaria
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 10025
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Prospective Grant of Exclusive Patent License: Inhibition of Plasmodial Surface Anion Channels for the Treatment or Prevention of Malaria,” thefederalregister.org (February 9, 2017), https://thefederalregister.org/documents/2017-02673/prospective-grant-of-exclusive-patent-license-inhibition-of-plasmodial-surface-anion-channels-for-the-treatment-or-preve.